These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32178357)

  • 21. Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates.
    McCluskie MJ; Pryde DC; Gervais DP; Stead DR; Zhang N; Benoit M; Robertson K; Kim IJ; Tharmanathan T; Merson JR; Davis HL
    Int Immunopharmacol; 2013 May; 16(1):50-6. PubMed ID: 23562759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats.
    LeSage MG; Keyler DE; Hieda Y; Collins G; Burroughs D; Le C; Pentel PR
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):409-16. PubMed ID: 15991003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
    Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
    J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New directions in nicotine vaccine design and use.
    Pentel PR; LeSage MG
    Adv Pharmacol; 2014; 69():553-80. PubMed ID: 24484987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic vaccines for nicotine dependence.
    Maurer P; Bachmann MF
    Curr Opin Mol Ther; 2006 Feb; 8(1):11-6. PubMed ID: 16506520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.
    Zhao Z; Hu Y; Harmon T; Pentel P; Ehrich M; Zhang C
    Biomaterials; 2017 Sep; 138():46-56. PubMed ID: 28551462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
    Rosenberg JB; De BP; Hicks MJ; Janda KD; Kaminsky SM; Worgall S; Crystal RG
    Hum Gene Ther; 2013 Jun; 24(6):595-603. PubMed ID: 23611296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity.
    Maurer P; Jennings GT; Willers J; Rohner F; Lindman Y; Roubicek K; Renner WA; Müller P; Bachmann MF
    Eur J Immunol; 2005 Jul; 35(7):2031-40. PubMed ID: 15971275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.
    Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M
    Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.
    Zeigler DF; Roque R; Clegg CH
    PLoS One; 2017; 12(6):e0178835. PubMed ID: 28570609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine conjugate vaccine as a novel approach to smoking cessation.
    Ottney AR
    Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical evaluation of a nicotine vaccine within a self-administration behavioral model.
    Moreno AY; Azar MR; Warren NA; Dickerson TJ; Koob GF; Janda KD
    Mol Pharm; 2010 Apr; 7(2):431-41. PubMed ID: 20104903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An In vivo study: Adjuvant activity of poly-n-vinyl-2-pyrrolidone-co-acrylic acid on immune responses against Melanoma synthetic peptide.
    Kızılbey K; Mansuroğlu B; Derman S; Mustafaeva Akdeste Z
    Bioengineered; 2018 Jan; 9(1):134-143. PubMed ID: 28910565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-free Synthetic Nicotine Vaccine Candidates with α-Galactosylceramide as Adjuvant.
    Chen XZ; Zhang RY; Wang XF; Yin XG; Wang J; Wang YC; Liu X; Du JJ; Liu Z; Guo J
    Mol Pharm; 2019 Apr; 16(4):1467-1476. PubMed ID: 30821985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum.
    de Villiers SH; Cornish KE; Troska AJ; Pravetoni M; Pentel PR
    Vaccine; 2013 Dec; 31(52):6185-93. PubMed ID: 24176492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.
    Zhao Z; Harris B; Hu Y; Harmon T; Pentel PR; Ehrich M; Zhang C
    Biomaterials; 2018 Feb; 155():165-175. PubMed ID: 29179132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical development of a vaccine 'against smoking'.
    Cerny EH; Lévy R; Mauel J; Mpandi M; Mutter M; Henzelin-Nkubana C; Patiny L; Tuchscherer G; Cerny T
    Onkologie; 2002 Oct; 25(5):406-11. PubMed ID: 12415193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.